Find all the financial documents relating to our investors classified in three main categories, by clicking below.
Welcome to the page dedicated to our shareholder Letters. We hope to make this communication tool a way of providing you with in-depth information on a regular basis to help you understand our strategy and how our projects are progressing.
The next Annual General Meeting of shareholders of Quantum Genomics will be held behind closed doors in the office of the company, on June 24, 2021 at 10 am.
The next Annual General Meeting of shareholders of Quantum Genomics will be held behind closed doors in the office of the company, on June 25, 2020 at 10 am.
The next annual general meeting of shareholders of Quantum Genomics company will be held Wednesday, June 27, 2019, at 10 am, in the offices of AARPI, located 36 Avenue Hoche, 75008 Paris.
The next annual general meeting of shareholders of Quantum Genomics company will be held Wednesday, June 14, 2018, at 10 am, in the offices of AARPI, located 36 Avenue Hoche, 75008 Paris.
The next annual general meeting of shareholders of Quantum Genomics company will be held Wednesday, June 8, 2017, at 10 am, in the offices of Orsay Avocats Associés, located 146/150 Champs Elysees – 75008 Paris.
All the resolutions were approved during the general meeting.
Holders of redeemable share subscription warrants issued on June 8, 2017 (BSAR 2017) are called to attend the Annual General Meeting on June 15, 2016 at 9:50 am in the offices of Orsay Avocats Associés, located 146/150 Champs Elysees – 75008 Paris.
The next annual general meeting of shareholders of Quantum Genomics company will be held Wednesday, June 15, 2016, at 10 am, in the offices of Orsay Avocats Associés, located 146/150 Champs Elysees – 75008 Paris.
Holders of redeemable share subscription warrants issued on March 14, 2016 (BSAR 2016) are called to attend the Annual General Meeting on June 15, 2016 at 9:50 am in the offices of Orsay Avocats Associés, located 146/150 Champs Elysees – 75008 Paris.
The general meeting of shareholders of Quantum Genomics company will be held Tuesday, December 22, 2015, at 10 am, in the offices of Orsay Avocats Associés, located 146/150 Champs Elysees – 75008 Paris.
The general meeting of shareholders of Quantum Genomics company will be held Tuesday, June 30, 2015, at 10 am, in the offices of Orsay Avocats Associés, located 146/150 Champs Elysees – 75008 Paris.
The general meeting of shareholders of Quantum Genomics company will be held Monday, June 30, 2014, at 4 pm, in the offices of SCP Lerner Friggeri & Associés (Cabinet Orsay), located 146/150 Champs Elysees – 75008 Paris.
Share capital of Quantum Genomics
Date : December 31, 2022
Total number of shares
Total number of voting rights
Containing 235,000 new shares issued in December 2022 according to free share plan AGA10-2021 validated by the October 4, 2021 Board of Directors
Main stock information
| ISIN Code | FR0011648971 |
| Mnemonic | ALQGC |
| Listing market | Alternext – Euronext Paris |
| PEA (Share savings plans) and PEA-PME | Yes |
| SRD (Deferred settlement) | No |
Quantum Genomics is a limited company with a board of directors. The compositions of the Board and Executive Committee of the Company are set out in the Company tab.
All publications will happen after the close of the Euronext markets.
April, 28th 2022
2021 Annual Results
June, 23rd 2022
General Meeting of Shareholders
October, 5th 2022
2022 Half-Year Results
For questions of financial order, please contact Benoit Gueugnon by completing the form.